{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:41Z","timestamp":1740108161901,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T00:00:00Z","timestamp":1524182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["4\/2005\/1327"],"award-info":[{"award-number":["4\/2005\/1327"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009584","name":"Clinical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009584","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Willy Gepts Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00125-018-4609-z","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T03:34:48Z","timestamp":1524195288000},"page":"1623-1632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients"],"prefix":"10.1007","volume":"61","author":[{"given":"Else M.","family":"Balke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simke","family":"Demeester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DaHae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hilbrands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursule","family":"Van de Velde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart J.","family":"Van der Auwera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart O.","family":"Roep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00ebl G.","family":"Pipeleers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Keymeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans K.","family":"Gorus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"key":"4609_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2337\/dc15-2768","volume":"39","author":"S Demeester","year":"2016","unstructured":"Demeester S, Balke EM, Van der Auwera BJ et al (2016) HLA-A*24 carrier status and autoantibody surges posttransplantation associate with poor functional outcome in recipients of an islet allograft. Diabetes Care 39:1060\u20131064","journal-title":"Diabetes Care"},{"key":"4609_CR2","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1073\/pnas.0705894104","volume":"104","author":"JM Wenzlau","year":"2007","unstructured":"Wenzlau JM, Juhl K, Yu L et al (2007) The cation efflux transporter ZnT8 (SLC30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 104:17040\u201317045","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4609_CR3","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.4049\/jimmunol.1003815","volume":"186","author":"M Dang","year":"2011","unstructured":"Dang M, Rockell J, Wagner R et al (2011) Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol 186:6056\u20136063","journal-title":"J Immunol"},{"key":"4609_CR4","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/db12-0071","volume":"61","author":"\u00c9 \u00c9n\u00e9e","year":"2012","unstructured":"\u00c9n\u00e9e \u00c9, Kratzer R, Arnoux JB et al (2012) ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes. Diabetes 61:1779\u20131784","journal-title":"Diabetes"},{"key":"4609_CR5","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.2337\/diabetes.53.9.2330","volume":"53","author":"F Chimienti","year":"2004","unstructured":"Chimienti F, Devergnas S, Favier A, Seve M (2004) Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53:2330\u20132337","journal-title":"Diabetes"},{"key":"4609_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00424-003-1070-7","volume":"447","author":"RD Palmiter","year":"2004","unstructured":"Palmiter RD, Huang L (2004) Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers. Pflugers Arch 447:744\u2013751","journal-title":"Pflugers Arch"},{"key":"4609_CR7","doi-asserted-by":"publisher","first-page":"21432","DOI":"10.1074\/jbc.M115.645291","volume":"290","author":"A Solomou","year":"2015","unstructured":"Solomou A, Meur G, Bellomo E et al (2015) The zinc transporter SLC30A8\/ZnT8 is required in a subpopulation of pancreatic alpha-cells for hypoglycemia-induced glucagon secretion. J Biol Chem 290:21432\u201321442","journal-title":"J Biol Chem"},{"key":"4609_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mce.2006.10.010","volume":"264","author":"K Smidt","year":"2007","unstructured":"Smidt K, Pedersen SB, Brock B et al (2007) Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obese. Mol Cell Endocrinol 264:68\u201373","journal-title":"Mol Cell Endocrinol"},{"key":"4609_CR9","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.2337\/db08-0522","volume":"57","author":"JM Wenzlau","year":"2008","unstructured":"Wenzlau JM, Liu Y, Yu L et al (2008) A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 57:2693\u20132697","journal-title":"Diabetes"},{"key":"4609_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00125-014-3405-7","volume":"58","author":"GA Rutter","year":"2015","unstructured":"Rutter GA, Chimienti F (2015) SLC30A8 mutations in type 2 diabetes. Diabetologia 58:31\u201336","journal-title":"Diabetologia"},{"key":"4609_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2337\/db07-0761","volume":"57","author":"ES Kang","year":"2008","unstructured":"Kang ES, Kim MS, Kim YS et al (2008) A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients. Diabetes 57:1043\u20132047","journal-title":"Diabetes"},{"key":"4609_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05616","volume":"445","author":"R Sladek","year":"2007","unstructured":"Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881\u2013885","journal-title":"Nature"},{"key":"4609_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng.2915","volume":"46","author":"J Flannick","year":"2014","unstructured":"Flannick J, Thorleifsson G, Beer NL et al (2014) Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 46:357\u2013363","journal-title":"Nat Genet"},{"key":"4609_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ng.2934","volume":"46","author":"E Pearson","year":"2014","unstructured":"Pearson E (2014) Zinc transport and diabetes risk. Nat Genet 46:323\u2013324","journal-title":"Nat Genet"},{"key":"4609_CR15","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41598-017-01762-9","volume":"7","author":"F Hosseini-Esfahani","year":"2017","unstructured":"Hosseini-Esfahani F, Mirmiran P, Koochakpoor G et al (2017) Some dietary factors can modulate the effect of the zinc transporters 8 polymorphism on the risk of metabolic syndrome. Sci Rep 7:1649","journal-title":"Sci Rep"},{"key":"4609_CR16","doi-asserted-by":"publisher","first-page":"E1084","DOI":"10.1152\/ajpendo.00448.2011","volume":"302","author":"AB Hardy","year":"2012","unstructured":"Hardy AB, Wijesekara N, Genkin I et al (2012) Effects of high-fat diet feeding on Znt8-null mice: differences between beta cell and global knockout of Znt8. Am J Physiol Endocrinol Metab 302:E1084\u2013E1096","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4609_CR17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2337\/dc16-2331","volume":"40","author":"CT Ferrara","year":"2017","unstructured":"Ferrara CT, Geyer SM, Liu YF et al (2017) Excess BMI in childhood: a modifiable risk factor for type 1 diabetes development? Diabetes Care 40:698\u2013701","journal-title":"Diabetes Care"},{"key":"4609_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/EJE-14-0522","volume":"172","author":"A Lauria","year":"2015","unstructured":"Lauria A, Barker A, Schloot N et al (2015) BMI is an important driver of beta cell loss in type 1 diabetes upon diagnosis in 10- to 18-year-old children. Eur J Endocrinol 172:107\u2013113","journal-title":"Eur J Endocrinol"},{"key":"4609_CR19","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.2337\/dc13-0128","volume":"36","author":"P Gillard","year":"2013","unstructured":"Gillard P, Hilbrands R, Van de Velde U et al (2013) Minimal functional beta-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients. Diabetes Care 36:3483\u20133488","journal-title":"Diabetes Care"},{"key":"4609_CR20","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1600-6143.2007.01777.x","volume":"7","author":"PM Campbell","year":"2007","unstructured":"Campbell PM, Salam A, Ryan EA et al (2007) Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am J Transplant 7:1242\u20131248","journal-title":"Am J Transplant"},{"key":"4609_CR21","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1111\/ajt.13407","volume":"15","author":"AM Brooks","year":"2015","unstructured":"Brooks AM, Carter V, Liew A et al (2015) De novo donor specific HLA antibodies are associated with rapid loss of graft function following islet transplantation in type 1 diabetes. Am J Transplant 15:3239\u20133246","journal-title":"Am J Transplant"},{"key":"4609_CR22","doi-asserted-by":"publisher","first-page":"17444","DOI":"10.1073\/pnas.0608141103","volume":"103","author":"B Keymeulen","year":"2006","unstructured":"Keymeulen B, Gillard P, Mathieu C et al (2006) Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci U S A 103:17444\u201317449","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4609_CR23","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1373\/clinchem.2008.109710","volume":"54","author":"PE Pauw De","year":"2008","unstructured":"De Pauw PE, Vermeulen I, Ubani OC et al (2008) Simultaneous measurement of plasma concentrations of proinsulin and C-peptide and their ratio with a trefoil-type time-resolved fluorescence immunoassay. Clin Chem 54:1990\u20131998","journal-title":"Clin Chem"},{"key":"4609_CR24","doi-asserted-by":"publisher","first-page":"E0166702","DOI":"10.1371\/journal.pone.0166702","volume":"11","author":"A Dalem Van","year":"2016","unstructured":"Van Dalem A, Demeester S, Balti EV et al (2016) Prediction of impending diabetes through automated dual-label measurement of proinsulin:C-peptide ratio. PLoS One 11:E0166702","journal-title":"PLoS One"},{"key":"4609_CR25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2337\/dc14-1575","volume":"38","author":"S Demeester","year":"2015","unstructured":"Demeester S, Keymeulen B, Kaufman L et al (2015) Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual beta cell function in recent-onset type 1 diabetes. Diabetes Care 38:644\u2013651","journal-title":"Diabetes Care"},{"key":"4609_CR26","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2337\/diacare.23.6.838","volume":"23","author":"K Decochez","year":"2000","unstructured":"Decochez K, Tits J, Coolens JL et al (2000) High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care 23:838\u2013844","journal-title":"Diabetes Care"},{"key":"4609_CR27","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.2337\/db12-0747","volume":"62","author":"E Mbunwe","year":"2013","unstructured":"Mbunwe E, Van der Auwera BJ, Vermeulen I et al (2013) HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients. Diabetes 62:1345\u20131350","journal-title":"Diabetes"},{"key":"4609_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-61737-954-3_6","volume":"700","author":"D Schleinitz","year":"2011","unstructured":"Schleinitz D, Distefano JK, Kovacs P (2011) Targeted SNP genotyping using the TaqMan\u00ae assay. Methods Mol Biol 700:77\u201387","journal-title":"Methods Mol Biol"},{"key":"4609_CR29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol 165:710\u2013718","journal-title":"Am J Epidemiol"},{"key":"4609_CR30","unstructured":"Collaborative Islet Transplant Registry (2016) 9th Annual Collaborative Islet Transplant Registry report. Available from www.citregistry.org\/content\/citr-9th-annual-report . Accessed 13 Sept 2017"},{"key":"4609_CR31","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.2337\/db12-1258","volume":"62","author":"L Piemonti","year":"2013","unstructured":"Piemonti L, Everly MJ, Maffi P et al (2013) Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes 62:1656\u20131664","journal-title":"Diabetes"},{"key":"4609_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2337\/diabetes.49.2.218","volume":"49","author":"S Braghi","year":"2000","unstructured":"Braghi S, Bonifacio E, Secchi A et al (2000) Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 49:218\u2013224","journal-title":"Diabetes"},{"key":"4609_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.diabet.2013.10.003","volume":"40","author":"MC Vantyghem","year":"2014","unstructured":"Vantyghem MC, Defrance F, Quintin D et al (2014) Treating diabetes with islet transplantation: lessons from the past decade in Lille. Diabetes Metab 40:108\u2013119","journal-title":"Diabetes Metab"},{"key":"4609_CR34","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa061267","volume":"355","author":"AM Shapiro","year":"2006","unstructured":"Shapiro AM, Ricordi C, Hering BJ et al (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318\u20131330","journal-title":"N Engl J Med"},{"key":"4609_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11892-017-0847-6","volume":"17","author":"N Othonos","year":"2017","unstructured":"Othonos N, Choudhary P (2017) Who should be considered for islet transplantation alone? Curr Diab Rep 17:23","journal-title":"Curr Diab Rep"},{"key":"4609_CR36","doi-asserted-by":"publisher","first-page":"e2435","DOI":"10.1371\/journal.pone.0002435","volume":"3","author":"V Huurman","year":"2008","unstructured":"Huurman V, Hilbrands R, Pinkse C et al (2008) Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One 3:e2435","journal-title":"PLoS One"},{"key":"4609_CR37","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.2337\/db09-0160","volume":"58","author":"R Hilbrands","year":"2009","unstructured":"Hilbrands R, Huurman VA, Gillard P et al (2009) Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 58:2267\u20132276","journal-title":"Diabetes"},{"key":"4609_CR38","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1210\/jc.2015-1216","volume":"100","author":"Z Ling","year":"2015","unstructured":"Ling Z, De Pauw P, Jacobs-Tulleneers D et al (2015) Plasma GAD65, a marker for early \u03b2-cell loss after intraportal islet cell transplantation in diabetic patients. J Clin Endocrinol Metab 100:2314\u20132321","journal-title":"J Clin Endocrinol Metab"},{"key":"4609_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11892-011-0217-8","volume":"11","author":"AMJ Shapiro","year":"2011","unstructured":"Shapiro AMJ (2011) State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep 11:345\u2013354","journal-title":"Curr Diab Rep"},{"key":"4609_CR40","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.2337\/db05-1049","volume":"55","author":"K Nakanishi","year":"2006","unstructured":"Nakanishi K, Inoko H (2006) Combination of HLA-A*24, -DQA1*03, and -DR9 contributes to acute-onset and early complete beta-cell destruction in type 1 diabetes: longitudinal study of residual beta-cell function. Diabetes 55:1862\u20131868","journal-title":"Diabetes"},{"key":"4609_CR41","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1056\/NEJMcibr0708067","volume":"358","author":"L Chatenoud","year":"2008","unstructured":"Chatenoud L (2008) Chemical immunosuppression in islet transplantation\u2014friend or foe? N Engl J Med 358:1192\u20131193","journal-title":"N Engl J Med"},{"key":"4609_CR42","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3109\/08916934.2011.576724","volume":"44","author":"LB Nielsen","year":"2011","unstructured":"Nielsen LB, Vaziri-Sani F, P\u00f6rksen S et al (2011) Relationship between ZnT8, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity 44:616\u2013623","journal-title":"Autoimmunity"},{"key":"4609_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000338665","volume":"77","author":"M Moosavi","year":"2012","unstructured":"Moosavi M, S\u00e9guin J, Li Q, Polychronakos C (2012) The effect of type 2 diabetes risk loci on insulin requirements in type 1 diabetes. Horm Res Paediatr 77:305\u2013308","journal-title":"Horm Res Paediatr"},{"key":"4609_CR44","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.2337\/db09-0551","volume":"58","author":"TJ Nicolson","year":"2009","unstructured":"Nicolson TJ, Bellomo EA, Wijesekara N et al (2009) Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58:2070\u20132083","journal-title":"Diabetes"},{"key":"4609_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/TP.0b013e3181aa7cc2","volume":"88","author":"CB Leit\u00e3o","year":"2009","unstructured":"Leit\u00e3o CB, Bernetti K, Tharavanij T et al (2009) Type 2 diabetes mellitus phenotype and graft survival after islet transplantation. Transplantation 88:57\u201361","journal-title":"Transplantation"},{"key":"4609_CR46","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/TP.0000000000000217","volume":"98","author":"DP Al-Adra","year":"2014","unstructured":"Al-Adra DP, Gill RS, Imes S et al (2014) Single-donor transplantation and long-term insulin-independence in select patients with type 1 diabetes mellitus. Transplantation 98:1007\u20131012","journal-title":"Transplantation"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4609-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4609-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4609-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T10:33:10Z","timestamp":1660991590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4609-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4609"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4609-z","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"type":"print","value":"0012-186X"},{"type":"electronic","value":"1432-0428"}],"subject":[],"published":{"date-parts":[[2018,4,20]]},"assertion":[{"value":"5 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}